Reference : Les traitements biologiques en rhumatologie
Scientific journals : Article
Human health sciences : Rheumatology
http://hdl.handle.net/2268/72447
Les traitements biologiques en rhumatologie
French
[en] Biological therapies in rheumatology
Von Frenckell, Christian mailto [Université de Liège - ULg > > Rhumatologie >]
Malaise, Michel mailto [Université de Liège - ULg > Département des sciences cliniques > Rhumatologie >]
2009
Revue Médicale de Liège
Hopital de Baviere
64
5-6
293-300
Yes (verified by ORBi)
National
0370-629X
Liège
Belgique
[en] Antibodies, Monoclonal ; Antirheumatic Agents ; Immunoglobulin Fab Fragments ; Immunoglobulin G ; Polyethylene Glycols ; Receptors, Tumor Necrosis Factor ; adalimumab ; golimumab ; infliximab
[en] Biological therapies consisting of monoclonal antibodies and soluble receptors
have revolutionized the care of rheumatologic patients. These therapies ensued
from a better understanding of the physiopathology of rheumatologic disorders.
Most of the latter have been concerned: rheumatoid arthritis (for about 10
years), psoriatic arthritis and ankylosing spondilitys (for more or less five
years). Rheumatology was among the first disciplines to make use of these
advances; it continues to benefit from the results of intense research efforts.
These developments request from clinicians an increased expertise in immunology.
Researchers ; Professionals ; Students ; General public
http://hdl.handle.net/2268/72447
http://www.rmlg.ulg.ac.be

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Malaise_2009_RevMedLiege_293-300.pdfPublisher postprint419.06 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.